Mr Kasavilas said there were only a few companies in the world owning a legal source of cannabis, approved for scientific and medical research under international drug conventions.
‘There’s a bottleneck at the very top all around the world, where researchers are in need of a lawful source of cannabis to do any kind of research so they can do clinical trials.
Might be a clue in there for the MCL IPO?
Ann: Trading Halt, page-167
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)